TOP TIERMARKET NEWSWIRE
SEC Form 4 history

THERAVANCE BIOPHARMA (TBPH) insider trades

THERAVANCE BIOPHARMA (TBPH) insider trading activity (SEC Form 4). Over the trailing 90 days, TBPH insiders filed 0 purchases totalling $0 and 3 sales totalling $6.1M — net SELLING of $6.1M. Most recent filing: Jul 8, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
3
$6.1M
Net (90d)
-$6.1M
net selling
Most recent
Jul 8, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Jul 8, 2026Samaha Eli10%S Sale—$17.14$119Kfiling
Jul 1, 2026Samaha Eli10%S Sale—$17.20$5.8Mfiling
Jun 17, 2026Farnum RhondaSVP, COMM, MEDICAL AFFAIRSS Sale—$16.39$218Kfiling